- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: VRC-FLUNPF099-00-VP (H1ssF_3928)
Total 170 results
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaboratorsWithdrawn
-
National Institute of Allergy and Infectious Diseases...United States Department of DefenseCompletedHIV InfectionsUganda, Kenya, Tanzania
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedRNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral DiseasesUnited States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HealthyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedTrial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy AdultsChikungunya Virus InfectionDominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HIV-1 | AIDS VaccinesUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInnate Immunity | HIV Negative | Adaptive ImmunityUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedEbola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | EbolavirusUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...International AIDS Vaccine InitiativeWithdrawn
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...The Emmes Company, LLC; US Military HIV Research ProgramCompletedHemorrhagic Fever, EbolaUganda
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Brazil, Haiti, Jamaica, South Africa
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedSafety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza A Virus, H1N1 Subtype | Novel Swine-OriginUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy | Healthy Volunteer | West Nile Fever | HVUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza A Virus, H5N1 Subtype | Influenza A Virus | Influenzavirus A | H5N1 Virus | OrthomyxovirdaeUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | HealthyUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedEbola Virus Disease | Ebola Hemorrhagic Fever | Ebola Virus Vaccines | Envelope Glycoprotein, Ebola Virus | FilovirusUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedPrevention of Zika Infection | Zika-Specific Immune ResponseUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedInfluenza A Virus, H5N1 Subtype | Influenza A Virus | Influenzavirus A | Orthomyxoviridae | H5N1 VirusUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...CompletedChikungunya Fever | Chikungunya Virus Infection | Viral VaccinesUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkTerminated